Kestra Advisory Services, LLC Cara Therapeutics, Inc. Transaction History

Kestra Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$12.38 - $29.19 $137,455 - $324,096	-11,103 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$15.07 - $21.71 $40,990 - $59,051	-2,720 Reduced 19.68%	11,103 $241,000
Q4 2020 Jan 20, 2021	BUY	$12.72 - $16.16 $26,635 - $33,839	2,094 Added 17.85%	13,823 $213 Million
Q3 2020 Nov 12, 2020	BUY	$12.34 - $17.92 $144,735 - $210,183	11,729 New	11,729 $149 Million

12.7M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $260M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.